Naurex Overview

  • Year Founded
  • 2006

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $1.72B

  • Investors
  • 1

Naurex General Information

Description

Developer of psychiatry and neurology treatment headquartered in Evanston, Illinois. The company develops therapies to address unmet needs in psychiatry and neurology based on a new mechanism of action for modulating the NMDA receptor in a safe way.

Contact Information

Website
www.naurex.com
Formerly Known As
Nyxis Neurotherapies
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 1801 Maple Avenue
  • Suite 4300
  • Evanston, IL 60201
  • United States
+1 (847)
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Acquirer
Vertical(s)
Corporate Office
  • 1801 Maple Avenue
  • Suite 4300
  • Evanston, IL 60201
  • United States
+1 (847)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Naurex Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Merger/Acquisition 28-Aug-2015 $1.72B Completed Clinical Trials - Phase 3
8. Later Stage VC (Series C) 02-Dec-2014 Completed Clinical Trials - Phase 3
7. Later Stage VC (Series B) 06-May-2014 Completed Clinical Trials - Phase 2
6. Early Stage VC (Series B) 17-Dec-2012 Completed Generating Revenue
5. Early Stage VC (Series A) 11-May-2011 Completed Startup
4. Later Stage VC 04-Feb-2011 Completed Startup
3. Early Stage VC 01-Mar-2008 Completed Startup
2. Early Stage VC (Series A) 05-Dec-2006 $2.26M $2.26M Completed Startup
1. University Spin-Out 01-Jan-2006 Completed Startup
To view Naurex’s complete valuation and funding history, request access »

Naurex Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series C
Series B
Series A 28,000,000 $0.010000 8% $0.91 $0.91 1x $0.91 21.71%
To view Naurex’s complete cap table history, request access »

Naurex Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of psychiatry and neurology treatment headquartered in Evanston, Illinois. The company develops therapies to a
Drug Discovery
Evanston, IL

Tampa, FL
 

Karachi, Pakistan
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Naurex Competitors (33)

One of Naurex’s 33 competitors is Pacira BioSciences, a Formerly VC-backed company based in Tampa, FL.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Pacira BioSciences Formerly VC-backed Tampa, FL
Pfizer Pakistan Corporation Karachi, Pakistan
Eisai Europe Corporation Hatfield, United Kingdom
Filana Therapeutics Formerly VC-backed Austin, TX
Curemark Venture Capital-Backed New York, NY
You’re viewing 5 of 33 competitors. Get the full list »

Naurex Patents

Naurex Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3986400-A1 Processes and intermediates for producing diazaspiro lactam compounds Active 24-Jun-2019
EP-3986400-A4 Processes and intermediates for producing diazaspiro lactam compounds Active 24-Jun-2019
EP-3986400-B1 Processes and intermediates for producing diazaspiro lactam compounds Active 24-Jun-2019
EP-3986400-C0 Processes and intermediates for producing diazaspiro lactam compounds Active 24-Jun-2019
EP-4484431-A2 Processes and intermediates for producing diazaspiro lactam compounds Pending 24-Jun-2019 C07D487/10
To view Naurex’s complete patent history, request access »

Naurex Former Investors (18)

Investor Name Investor Type Holding Investor Since Participating Rounds
Adams Street Partners PE/Buyout Minority
Baxter Ventures Corporate Venture Capital Minority
Cowen Healthcare Investments Venture Capital Minority
Druid BioVentures Venture Capital Minority
EcoR1 Capital Venture Capital Minority
You’re viewing 5 of 18 investors. Get the full list »

Naurex FAQs

  • When was Naurex founded?

    Naurex was founded in 2006.

  • Where is Naurex headquartered?

    Naurex is headquartered in Evanston, IL.

  • What industry is Naurex in?

    Naurex’s primary industry is Drug Discovery.

  • Is Naurex a private or public company?

    Naurex is a Private company.

  • What is the current valuation of Naurex?

    The current valuation of Naurex is .

  • What is Naurex’s current revenue?

    The current revenue for Naurex is .

  • How much funding has Naurex raised over time?

    Naurex has raised $165M.

  • Who are Naurex’s investors?

    Adams Street Partners, Baxter Ventures, Cowen Healthcare Investments, Druid BioVentures, and EcoR1 Capital are 5 of 18 investors who have invested in Naurex.

  • Who are Naurex’s competitors?

    Pacira BioSciences, Pfizer Pakistan, Eisai Europe, Filana Therapeutics, and Curemark are some of the 33 competitors of Naurex.

  • When was Naurex acquired?

    Naurex was acquired on 28-Aug-2015.

  • Who acquired Naurex?

    Naurex was acquired by Allergan.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process